NeoGenomics Inc (NEO)
Net profit margin
Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net income (ttm) | US$ in thousands | -87,968 | -96,329 | -114,665 | -125,637 | -144,250 | -163,322 | -146,818 | -35,642 | -8,348 | 48,828 | 71,733 | -10,964 | 4,172 | -4,949 | -5,363 | 3,452 | 8,006 | 2,063 | 1,943 | -428 |
Revenue (ttm) | US$ in thousands | 601,638 | 580,487 | 554,336 | 529,041 | 507,523 | 493,983 | 486,680 | 484,258 | 482,622 | 482,400 | 486,504 | 451,757 | 442,254 | 425,319 | 404,547 | 419,283 | 408,830 | 378,437 | 342,861 | 308,894 |
Net profit margin | -14.62% | -16.59% | -20.69% | -23.75% | -28.42% | -33.06% | -30.17% | -7.36% | -1.73% | 10.12% | 14.74% | -2.43% | 0.94% | -1.16% | -1.33% | 0.82% | 1.96% | 0.55% | 0.57% | -0.14% |
December 31, 2023 calculation
Net profit margin = Net income (ttm) ÷ Revenue (ttm)
= $-87,968K ÷ $601,638K
= -14.62%
Neogenomics Inc.'s net profit margin has shown a downward trend over the past eight quarters, declining from -7.33% in Q1 2022 to -23.71% in Q1 2023. The company experienced significant fluctuations in profitability, with the lowest net profit margin recorded in Q3 2022 at -32.88%. This indicates that the company's ability to generate profit from its revenue has been deteriorating over time. It is important for Neogenomics Inc. to closely monitor and address the factors contributing to this decline in profitability to ensure sustainable financial performance in the future.